Product Image

Melatonin 1.0 mg Orange Flavor

Source Naturals Sleep Science
4.7
★ ★ ★ ★ ★
(460 ratings)
Melatonin 1 mg
Product Image
Score88
A low-dose orange dissolving melatonin option with excellent serving value. It is designed for sleep onset, not overnight maintenance.
How scoring works
Quantity:300 Liquid(s) • (300 servings)
Goals:
Sleep Support

Score 88

A low-dose orange dissolving melatonin option with excellent serving value. It is designed for sleep onset, not overnight maintenance.
How scoring works
$17.85($0.05 per serving)
iHerb
$ 17.85
Vitacost
$ 17.85
Report prices

Analysis

A 1 mg melatonin amount is well aligned with a low-dose approach to sleep timing. The orange-flavored dissolving format may make the bedtime signal relatively quick and easy to use.

No unnecessary active ingredients complicate the formula. Lack of sustained release limits its fit for people who can fall asleep but wake repeatedly.

Three hundred servings provide exceptional practical value and reduce replacement frequency. Flavor preference is the main consideration beyond the release profile.

Who is it for
  • Adults seeking 1 mg melatonin
  • Users who prefer orange flavor
  • People wanting a large supply
Best for
  • Prompt sleep-onset support
  • Cautious dosing
  • Long-term value

Pros

  • Low 1 mg amount
  • Three hundred servings
  • Simple active profile

Cons

  • No sustained-release feature
  • No additional calming pathway
  • Flavored format may not suit everyone

Warnings

  • Melatonin may cause next-day drowsiness or vivid dreams
  • Avoid alertness-dependent tasks if grogginess persists

Nutrient quality

95 Highest impact

The 1 mg amount is well aligned with low-dose sleep support. The dissolving format may support quicker onset but not overnight release.

.

Ingredient transparency

85 Highest impact

Active amounts are clear without a hidden blend. Complete directions and inactive ingredients remain unavailable.

.

Customer satisfaction

70 High impact

The supplied average is strong and supported by substantial volume. No review themes were provided, so consistency and purpose-specific experience cannot be assessed.

.

Value for money

99 Highest impact

A very low serving cost and clearly stated dose support value. Missing release tailoring and purity verification limit differentiation.

.
Report analysis

Goals

Sleep Support
Impact
Highest effect
A+ Goal FitA+ Strength of SupportC+ CoverageA+ Formula Quality
Melatonin · 1 mg

The low melatonin dose directly supports the sleep-wake cycle and may make sleep onset easier. The dissolving lozenge is particularly well suited to a relatively quick bedtime signal.

The 1 mg amount is clear and well aligned with physiological dosing. The immediate-release design does not provide sustained support for people whose main problem is waking during the night.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
1 mg
Adults 18–50 Women
Report overview
Melatonin · 1 mg OverallScore76
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The dissolving lozenge format may support a relatively quick onset for sleep initiation. The modest single-unit melatonin amount is easy to understand and aligns well with physiological dosing. Lack of sustained-release technology and independent purity verification are the main limitations, while the serving cost is highly economical.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
    Salanitro M; Wrigley T; Ghabra H; de Haan E; Hill CM; Solmi M; Cortese S · Neuroscience and biobehavioral reviews · 2022
    Meta-analysis1,998 participants34 studies pooledSleep Support forMelatonin
  3. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  4. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  5. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  6. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  7. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin